暂无数据
代码股票名称
最新价涨跌额涨跌幅成交量成交额今开昨收最高最低总市值流通市值总股本流通股本5日涨跌幅10日涨跌幅20日涨跌幅60日涨跌幅120日涨跌幅250日涨跌幅年初至今涨跌幅股息率TTM换手率市盈率TTM市盈率(静)振幅所属行业
美股市场个股详情
MOH Molina Healthcare
- 339.680
- +0.130+0.04%
收盘价 05/03 16:00 (美东)
- 339.680
- 0.0000.00%
盘后 16:44 (美东)
199.05亿总市值18.44市盈率TTM
341.450最高价336.290最低价37.46万股成交量339.070今开339.550昨收1.27亿成交额0.65%换手率18.10市盈率(静)5860.00万总股本423.92452周最高4.43市净率196.58亿流通值266.35052周最低--股息TTM5787.30万流通股423.924历史最高--股息率TTM1.52%振幅10.747历史最低339.722平均价1股每手
全部分时
- 5日
- 日K
- 周K
- 月K
- 季K
- 年K
资金分布
单位: --
资金流向
实时日周月
暂无数据
新闻
随着医疗费用趋势的迅速下调，CVS 健康状况下降
20 年前投资于 Molina Healthcare 的 1000 美元，今天的价值将如此之高
在过去的20年中，莫利纳医疗保健（纽约证券交易所代码：MOH）的年化表现比市场高6.52％，平均年回报率为14.41％。目前，Molina Healthcare有一个市场
莫利纳医疗保健公司（纽约证券交易所代码：MOH）2024年第一季度财报电话会议记录
TD Cowen 将莫利纳的健康维持在买入水平
TD Cowen 将莫利纳的健康维持在买入水平
道明考恩将莫利纳医疗的目标股价从453美元调整至412美元，维持买入评级
Capital IQ调查的分析师表示，莫利纳医疗保健（MOH）的平均评级为跑赢大盘，目标股价在354美元至442美元之间。
分析师提供有关医疗保健公司的见解：艾伯维（ABBV）、莫利纳医疗保健（MOH）和细胞动力学（CYTK）
评论
$Molina Healthcare(MOH.US$ 🎯 2024.4.8 当前价格377.73，持仓浮盈23.8%
新增数据：23Q4，营收增长10%，营业利润受毛利率下滑影响仅增长1%，净利润由于没有去年的大笔勾销，不出所料的大幅提升。
2023年营收增长6.6%，营业利润增长13.9%，净利润增长37.8%，利息费用占营业利润的6.9%，这比较意外，因为现金91.07亿，欠款只有21.8亿，应该有利息收入才对。净资产收益率提高到了30.4%。
资产负债率从75.9%下降到71.7%，资产端以流动资产为主，现金大幅增加，应收增长较多，比例仍然正常。负债端应付款项增加较多，长期借款占净资产的52%变化不大。
现金流经营净额高于投资净额，产生较多股东盈余。
目前市盈率20.1，估值在合理区间，暂不做调整。
新增数据：23Q4，营收增长10%，营业利润受毛利率下滑影响仅增长1%，净利润由于没有去年的大笔勾销，不出所料的大幅提升。
2023年营收增长6.6%，营业利润增长13.9%，净利润增长37.8%，利息费用占营业利润的6.9%，这比较意外，因为现金91.07亿，欠款只有21.8亿，应该有利息收入才对。净资产收益率提高到了30.4%。
资产负债率从75.9%下降到71.7%，资产端以流动资产为主，现金大幅增加，应收增长较多，比例仍然正常。负债端应付款项增加较多，长期借款占净资产的52%变化不大。
现金流经营净额高于投资净额，产生较多股东盈余。
目前市盈率20.1，估值在合理区间，暂不做调整。
专栏Market Pull Back? Finally? | Wall Street Today
RECAP
April rain better mean the stock market stops the pain by May: the market declined Tuesday, punctuated by the fall of fan favorite Tesla. The EV maker made less EV's than last year and dropped nearly 5%.
Stocks closed lower, the $标普500指数(.SPX.US$ was recently down about 0.72%. $纳斯达克100指数(.NDX.US$ fell about 0.94%. $道琼斯指数(.DJI.US$ fell 1%.
MACRO
Job openings recorded by JOLTS were just shy of expectations...
April rain better mean the stock market stops the pain by May: the market declined Tuesday, punctuated by the fall of fan favorite Tesla. The EV maker made less EV's than last year and dropped nearly 5%.
Stocks closed lower, the $标普500指数(.SPX.US$ was recently down about 0.72%. $纳斯达克100指数(.NDX.US$ fell about 0.94%. $道琼斯指数(.DJI.US$ fell 1%.
MACRO
Job openings recorded by JOLTS were just shy of expectations...
42
4
Recent insider selling at Molina Healthcare may hint at insiders believing the shares are overpriced. Despite profitability and profit growth, the absence of insider buying and recent selling could caution investors.
Analysts' sentiment remains steady post latest results, with a minor rise in revenue forecasts. Despite EPS missing estimates, earnings continue to be the value driver. Molina Healthcare's revenue growth rate is expected to surpass the industry.
1
Molina Healthcare's high P/E ratio is justified by its strong forecast growth, surpassing the wider market. Investors see insignificant potential for earnings deterioration, hence a lower P/E ratio isn't warranted. Share price drop in near future is unlikely.
阅读更多
分析
目标价预测
暂无数据
热议
美股
综合热度
股票代码
最新价
涨跌幅